Q1 2024 Cellectis SA Earnings Call Transcript
Good morning, everyone, and welcome to the Cellectis first-quarter 2024 earnings call. (Operator Instructions) Please be aware that today's conference call is being recorded.
I'd now like to turn the conference over to your first speaker Arthur Stril, Interim Chief Financial Officer. You may begin.
Good morning, and welcome, everyone, to Cellectis first quarter 2024 corporate update and financial results conference call. Joining me on the call today are Dr. André Choulika, our Chief Executive Officer, and Dr. Mark Frattini, our Chief Medical Officer.
Yesterday evening, Cellectis issued a 6-K and a press release reporting our financial statements for the three month period ending March 31, 2024, and a corporate and business update. The report and press release are available on our website at cellectis.com.
As a reminder, we will make statements regarding Cellectis financial outlook, including the sufficiency of cash to fund operations in addition to its manufacturing,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |